Skip to main content
. Author manuscript; available in PMC: 2022 Dec 1.
Published in final edited form as: Oral Oncol. 2021 Oct 26;123:105574. doi: 10.1016/j.oraloncology.2021.105574

Table 1.

Patient details.

Patient details N (%)
Age at Surgery
Median 60
IQR 53–68
Range 29 – 84
Histology
SCC 75 (94%)
Adenoid Cystic 4 (5%)
Ameloblastoma 1 (1%)
AJCC Stage (1)
I 11 (14%)
II 10 (13%)
III 13 (17%)
IVa 41 (54%)
IVb 1 (1%)
Additional Treatment
None 17 (21%)
Radiation 30 (38%)
Chemoradiation 33 (41%)
Treatment for recurrence 14 (18%)
Treatment for second primary 15 (19%)
Free Flap
ALT 18 (22%)
Fibula 36 (45%)
Radial Forearm 18 (22%)
Other 8 (10%)
Second Simultaneous Flap 3 (4%)
Composite Resection 56 (70%)
Oral Tongue Resection 24 (30%)
Composite Site
Lateral 38 (68%)
Anterior 18 (32%)
Oropharyngeal Component 28 (35%)
Extent of Tongue Resection
None 29 (36%)
< 1/3 14 (18%)
1/3 – 1/2 29 (36%)
  > 1/2 8 (10%)
Mandibulectomy
Segmental 45 of 56 (80%)
Marginal 11 of 56 (20%)
(1)

Four patients were missing AJCC Stage.